RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 96 filers reported holding RECRO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $227,000 | +56.6% | 110,088 | +75.0% | 0.00% | – |
| Q2 2021 | $145,000 | +245.2% | 62,891 | +319.3% | 0.00% | – |
| Q1 2021 | $42,000 | -92.0% | 15,000 | -94.0% | 0.00% | -100.0% |
| Q3 2020 | $523,000 | -45.2% | 249,235 | +18.7% | 0.00% | -60.0% |
| Q2 2020 | $955,000 | -33.0% | 209,963 | +20.4% | 0.01% | -58.3% |
| Q1 2020 | $1,425,000 | -77.5% | 174,373 | -49.5% | 0.01% | -36.8% |
| Q4 2019 | $6,331,000 | +3760.4% | 345,415 | +2231.2% | 0.02% | +1800.0% |
| Q3 2019 | $164,000 | +11.6% | 14,817 | +2.2% | 0.00% | – |
| Q2 2019 | $147,000 | -93.0% | 14,500 | -92.4% | 0.00% | -100.0% |
| Q1 2018 | $2,095,000 | +1177.4% | 190,247 | +973.6% | 0.01% | +600.0% |
| Q4 2017 | $164,000 | -63.8% | 17,721 | -65.8% | 0.00% | -50.0% |
| Q1 2017 | $453,000 | – | 51,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |